Jason Richardson is recorded as CFO at Inogen Inc (INGN). The newest filing on record that lists Jason Richardson as CFO at Inogen Inc (INGN) is dated April 28, 2026. Inogen Inc reported in an 8-K filed March 30, 2026 that Jason Richardson was appointed Executive Vice President, Chief Financial Officer and Treasurer, effective April 6, 2026. Jason Richardson has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for Inogen Inc on November 5, 2026. Inogen Inc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Inogen Inc includes Andrew (“Andy”) P. Reding (CEO and Board Member), Elizabeth Mora (Chairman and Board Member), Kristin A. Caltrider (CFO) and 7 others.
“On March 24, 2026, the Board of Directors (“Board”) of Inogen, Inc. (the “Company”) appointed Jason Richardson to serve as Executive Vice President, Chief Financial Officer and Treasurer “CFO” of the Company, effective April 6, 2026.”
“Let me start with an update on the U.S. Oxygen rental divestiture. The transaction closed on November 2nd for a total estimated cash consideration of up to $24.8 million, which we expect to receive in the first half of 2027.”
“As Kevin mentioned, total revenue for the second quarter was $95.1 million, an increase of 3% from the prior year period, primarily driven by strong international growth, the favorable impact of foreign exchange rates, and new product contributions.”
“I'm excited to be here for my first earnings call as Inogen CFO. I joined the company just one month ago, and I've been spending that time getting deeply into the business and getting to know the team and the opportunities ahead.”
“So we're growing faster than the market from the unit volume basis there, but we are – but more of it is coming from the lower price set. okay and then maybe I would add there too that you know I think a big part of the product launches we've been talking about is a big component of that expanding margin going forward…”
